Misleading Ads: Supreme Court Warns States Of Contempt Action For Inaction
The Supreme Court issued a warning to states on Wednesday, threatening to initiate a contempt action for their inaction over complaints of misleading ads against modern medicine.
A division bench, led by Justice Abhay S Oka, remarked that the Delhi government's explanation that identifying offenders was challenging was "peculiar". The court also asked other states for the status reports for actions taken on the basis of complaints received.
The top court, thereafter, said that it would consider compliances by Andhra Pradesh, Delhi, Goa, Gujarat and Jammu & Kashmir on Feb 10.
It also discharged RV Asokan, president of the Indian Medical Association, of contempt charges over his comments against the top court's observations in the misleading ads case.
In April, Asokan, in an interview with the Press Trust of India, remarked that it was "unfortunate" that the top court was criticising the IMA, as well as some of the practices of private doctors.
Asokan's remarks followed the court's criticism of the IMA, wherein it was stated that the association needed to address several complaints about unethical practices. At the time, the apex court took a strong exception to his comments and directed him to issue a public apology, which he eventually did.
The case began in November 2023, when the apex court issued a stern warning to Ramdev and his multinational conglomerate for downplaying the effects of modern medicine. Some of Patanjali's commercials claimed its medicines could cure a number of illnesses while simultaneously disparaging modern medicine.
The court had said that it would issue a hefty penalty for all those misleading advertisements that promise to cure diseases such as asthma, obesity, and the like.
At the time, Patanjali told the court that it would make sure that going forward, no casual statements claiming medicinal efficacy against any system of medicine would be released to the media in any form.
However, a day after the court's stern remarks, Patanjali came out with a media statement saying that it was not making any "false advertisements or propaganda" regarding its products and that it would not object if the top court were to impose a fine or "even give us a death sentence" if found making misleading claims.
This prompted the apex court to come down on Ramdev and his conglomerate with all guns blazing for openly flouting court orders.
The entire fiasco has also led the court to reprimand the Union government and various other authorities for their inaction on the wider issue of misleading advertisements for drugs and medicines.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.